Publicaties

Hier vindt u alle publicaties, geschreven door onze specialisten.

Prospective Validation of Circulating Tumor DNA Measurable Residual Disease After First-Line Therapy in Large B-Cell Lymphoma.

Uncovering the ultra-frail: A distinct subgroup in non-transplant eligible newly diagnosed patients with multiple myeloma, with an inferior clinical outcome.

Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia.

Trends in asthma exacerbations in children before, during and after the COVID-19 pandemic

Fixed-duration ibrutinib-venetoclax with MRD-guided ibrutinib-obinutuzumab intensification in first-line chronic lymphocytic leukaemia (HOVON 158/NEXT STEP): primary analysis of a multicentre, open-label, phase 2 trial.